Yohimbe / Yohimbine: Alpha-2 Adrenergic Antagonist for Fat Loss & Sexual Function — Significant Safety Concerns
⚡ 60-Second Summary
Yohimbine (17α-hydroxy-yohimban-16α-carboxylic acid methyl ester) is an alkaloid from the bark of Pausinystalia yohimbe (Central African tree). It acts as a selective alpha-2 adrenergic receptor antagonist, blocking the receptors that inhibit norepinephrine release. By blocking alpha-2 receptors, yohimbine increases norepinephrine, stimulates the sympathetic nervous system, and — critically — specifically addresses the 'stubborn fat' areas in men (lower abdomen/flanks) and women (hips/thighs) that have high alpha-2 receptor density.
Best-evidenced applications: fat loss from high-alpha-2 receptor sites (lower belly in men, hips/thighs in women — an application with unique mechanistic rationale not shared by caffeine), erectile dysfunction (small RCTs, historically used as FDA-regulated prescription Yocon), and antidepressant augmentation (increased norepinephrine in treatment-resistant depression). All applications require significant safety monitoring.
Yohimbine is one of the highest-risk commonly sold supplements — FDA has warned about serious adverse events including heart attacks and seizures. The supplement market has significant dose variability (one study found declared doses ranging from 0% to 147% of the labeled amount in 49 products). Medical supervision is strongly advisable.
What is Yohimbe / Yohimbine?
Yohimbe bark has been used in West and Central Africa as an aphrodisiac and stimulant for centuries. Pharmaceutical yohimbine HCl was approved by FDA as Yocon for male sexual dysfunction (removed from OTC market but available by prescription). Sports nutrition interest emerged in the 1990s as a fat-loss supplement. The FDA has warned about yohimbe dietary supplements multiple times.
Yohimbine is one of the few supplements that crosses from dietary supplement to pharmaceutical use — Yocon (pharmaceutical yohimbine HCl) is a prescription drug in the US for erectile dysfunction.
Evidence-based benefits
Fat Loss — Stubborn Areas
Alpha-2 receptors in adipose tissue inhibit fat mobilization; areas with high alpha-2 density (lower belly in men, gluteal/thigh in women) are resistant to fat loss. Yohimbine's alpha-2 blockade specifically addresses this mechanism. A controlled trial (Ostojic 2006, Research in Sports Medicine) of soccer players showed yohimbine HCl 20 mg/day for 21 days significantly reduced body fat versus placebo. A second trial (Talpur 2002) confirmed fat reduction but not weight loss (suggests water redistribution). Effects appear most meaningful in trained individuals with already low body fat.
Erectile Dysfunction
Multiple small RCTs show yohimbine HCl improves erectile function in men with psychological and organic erectile dysfunction. A meta-analysis (Ernst and Pittler, 1998) of 7 trials concluded yohimbine is significantly more effective than placebo for erectile dysfunction. This led to FDA prescription approval (Yocon). Phosphodiesterase-5 inhibitors (Viagra, Cialis) have since replaced yohimbine in most treatment guidelines due to superior efficacy and safety profile.
Weight Management Combined with Exercise
Yohimbine appears most effective combined with fasted training. Alpha-2 blockade during fasted cardio specifically addresses hormonal resistance to fat mobilization in stubborn adipose areas. Studies in fasted conditions show superior results compared to non-fasted. This is the basis for the 'fasted cardio + yohimbine' protocol popular in physique sports.
Autonomic and Antidepressant
Case reports and small trials support yohimbine augmentation in treatment-resistant depression through increased norepinephrine. Not a primary psychiatric treatment; interesting mechanistically but not an established clinical application for self-supplementation.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Form | Dose | Best For | Notes |
| Yohimbine HCl (pharmaceutical-grade) | 5–20 mg/day in divided doses | Fat loss and erectile dysfunction — most consistent and predictable | Preferred over whole yohimbe bark; precise dosing possible; start at 2.5–5 mg to assess tolerance |
| Yohimbe Bark Extract (standardized alkaloids) | Standardized to 2–5 mg yohimbine HCl equivalent | Traditional form; broader alkaloid profile | Variable yohimbine content makes dosing unpredictable; verify label yohimbine content |
| Prescription Yohimbine HCl (Yocon) | 5.4 mg 3x/day (standard prescription dose) | Erectile dysfunction under medical supervision | Physician-supervised; dose titration and monitoring available |
| Pre-workout blends with yohimbine | Varies — often unlisted or inaccurately dosed | Stimulant and fat-burning pre-workout stacks | Significant dose variability; read label carefully; start with partial serving to assess tolerance |
How much should you take?
- Start at 2.5 mg yohimbine HCl and titrate upward over 1–2 weeks to 5–20 mg/day based on tolerance
- Divide total dose (e.g., 5–10 mg twice daily) to reduce peak plasma concentration and side effects
- For stubborn fat loss: take in fasted state before cardio (combines fasted state benefits with alpha-2 blockade)
- Total dose above 20 mg/day significantly increases adverse effect risk; most evidence is at 5–20 mg/day
Yohimbine dose variability in supplements is a major safety concern. A 2016 analysis (Cohen et al., Drug Testing and Analysis) found 49 yohimbine supplements ranged from 0 to 147% of the labeled dose. This variability is dangerous given yohimbine's narrow therapeutic-to-adverse-effect window. Purchase from reputable manufacturers with third-party dose verification.
Safety and side effects
Common side effects
- Elevated heart rate and blood pressure — can be significant; contraindicated in hypertension
- Anxiety, panic attacks, and psychiatric effects in predisposed individuals — significant risk
- Nausea, vomiting, headache
- Insomnia — take early in the day
- Serious adverse events: cardiac arrhythmias, heart attacks, seizures reported; FDA safety warnings issued
- Dangerous at high doses — seek medical attention for palpitations, chest pain, severe anxiety, seizures
Serious risks
Yohimbine is one of the highest-risk commonly sold supplement ingredients. The FDA has issued multiple safety advisories. Absolute contraindications include: hypertension, heart disease, psychiatric conditions (anxiety disorders, PTSD, bipolar disorder, schizophrenia), liver or kidney disease, and any current use of MAO inhibitors. Medical supervision is strongly advisable for all uses.
Drug and nutrient interactions
- MAO inhibitors (MAOIs) — DANGEROUS; additive adrenergic effects; potentially fatal interaction; ABSOLUTE contraindication
- Antidepressants (SSRIs, SNRIs, TCAs) — increased serotonergic and noradrenergic stimulation; serotonin syndrome risk with certain combinations
- Antihypertensives — yohimbine raises blood pressure; directly opposes antihypertensive medications
- Stimulants (caffeine, amphetamines) — additive cardiovascular stimulation; significant risk at combined doses
- Diabetes medications — alpha-2 blockade affects insulin secretion; glucose monitoring required
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Trained athletes with already low body fat seeking to address stubborn fat areas (lower belly, hips/thighs) under medical guidance | People with hypertension, heart disease, or cardiovascular risk — significant cardiovascular adverse effects; contraindicated |
| Men with erectile dysfunction under physician supervision and monitoring | People with anxiety disorders, PTSD, or psychiatric conditions — significant anxiety and panic induction risk; contraindicated |
| Exercise physiology-oriented individuals who understand the alpha-2 mechanism and respect the safety profile | People taking MAO inhibitors — ABSOLUTE contraindication; potentially fatal interaction |
| Beginners to supplementation — yohimbine is inappropriate as a first supplement; too many safety considerations |
Frequently asked questions
Why does yohimbine target 'stubborn fat' specifically?
Adipose tissue in different body areas has different ratios of alpha-1 (fat-mobilizing) and alpha-2 (fat-inhibiting) adrenergic receptors. Lower belly fat in men and gluteal/thigh fat in women have particularly high alpha-2 receptor density — this is why these areas resist fat loss even with caloric deficit and exercise. Yohimbine specifically blocks alpha-2 receptors, removing the 'brake' on norepinephrine-stimulated fat mobilization in these areas. No other commonly available supplement has this specific mechanistic targeting of high-alpha-2 fat deposits.
What are the most serious risks with yohimbine?
Serious adverse events include: cardiac arrhythmias, hypertensive crisis, heart attack, and seizures — these have been reported in FDA adverse event reports and the medical literature. The cardiac risks are most significant in people with underlying heart disease or hypertension. Psychiatric risks (severe anxiety, panic attacks, psychosis exacerbation) are most significant in those with psychiatric conditions or anxiety disorders. These are not theoretical — they are documented in the FDA CFSAN Adverse Event Reporting System.
Is yohimbe bark safer than yohimbine HCl?
No — yohimbe bark is generally less predictable and potentially more problematic than pharmaceutical-grade yohimbine HCl. The bark contains multiple alkaloids whose interactions are complex; total yohimbine content in bark products is highly variable. Pharmaceutical yohimbine HCl allows precise dosing and titration. If yohimbine is used at all, pharmaceutical-grade yohimbine HCl from reputable manufacturers with verified dose is preferable to bark extracts.
Can I take yohimbine with caffeine?
Combining yohimbine with caffeine adds cardiovascular stimulation effects — increased heart rate, blood pressure, and adrenergic tone. Many pre-workout supplements combine both, but this combination can be problematic for individuals who are sensitive to either compound individually. If combining, start with very low doses of both, ensure you don't have cardiovascular or psychiatric contraindications, and monitor your response carefully.
Related ingredients
Caffeine Anhydrous
Primary stimulant often combined with yohimbine; different fat-loss mechanism.
Synephrine (Bitter Orange)
Alternative adrenergic fat-loss compound with fewer psychiatric effects.
Green Tea Extract
Safer fat-oxidation supplement with antioxidant benefits.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.